Screening for pregestational and gestational diabetes in pregnancy: a survey of obstetrical centers in the northern part of Belgium
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
BACKGROUND: There is lack of consensus concerning the best screening strategy for gestational diabetes (GDM). The aim of our survey was therefore to investigate attitudes and practices of all obstetrical centers in the northern part of Belgium regarding screening for pregestational diabetes in early pregnancy and screening for GDM. We also aimed to identify the penetrance of the 'International Association of Diabetes in Pregnancy Study Groups' (IADPSG) screening strategy for GDM. METHODS: The survey was conducted from May 2012 till January 2013. The survey was distributed to every obstetrical center in the northern part of Belgium by email and/or mail with reminders by phone and personal contact. RESULTS: From the 65 obstetrical centers, 69% responded. Of all centers, 27% had a structured database on the number of women with GDM. Of all centers, 82% screened for pregestational diabetes in early pregnancy and 56% of centers screened for GDM before 24 weeks. Screening before 24 weeks was mostly based on risk factors. Screening for GDM after 24 weeks, was done universally in 87% of centers. The mean estimated prevalence of GDM was 7 ± 5%. The most commonly used screening strategy was a two-step approach with a glucose challenge test (GCT) and 100 g oral glucose tolerance test (OGTT), used by 56% of centers, with 23 centers using the Carpenter & Coustan criteria. The 75 g OGTT with the IADPSG criteria was used by 33% of centers but 4 of these centers still used a GCT before proceeding to the full OGTT. CONCLUSIONS: This survey demonstrates that in the northern part of Belgium, there still is a large variation in screening strategy for pregestational diabetes in early pregnancy and GDM. Only 25% of centers have already implemented the one-step IADPSG screening strategy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s062 · Cited by 1,817
Lawrence, J. M., Contreras, R., Chen, W., & Sacks, D. A. (2008) · Diabetes Care · doi:10.2337/dc07-2345 · Cited by 658
Buckley, B. S., Harreiter, J., Damm, P., Corcoy, R., Chico, A., Simmons, D., Vellinga, A., Dunne, F., & on behalf of the DALI Core Investigator Group (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03541.x · Cited by 360
Zhu, W.-W., Yang, H.-X., Wei, Y.-M., Yan, J., Wang, Z.-L., Li, X.-L., Wu, H.-R., Li, N., Zhang, M.-H., Liu, X.-H., et al. (2013) · Diabetes Care · doi:10.2337/dc12-1157 · Cited by 338 · cited 1×
“A recent evaluation of the FPG in the first prenatal visit to diagnose GDM in China showed that a FPG between 110-125 mg/dl was a much better predictor of the development of GDM and that for their population at least, a FPG ≥ 92mg/dl at first prenatal visit could not be supported as the criterion for diagnosis of GDM…”
BackgroundBenhalima, K., Hanssens, M., Devlieger, R., Verhaeghe, J., & Mathieu, C. (2013) · International Journal of Endocrinology · doi:10.1155/2013/248121 · Cited by 73
Self-citation
Cited by
Gestational diabetes mellitus: An update on the current international diagnostic criteria
Agarwal, M. M. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i6.782 · Cited by 128
Benhalima, K., Mathieu, C., Damm, P., Van Assche, A., Devlieger, R., Desoye, G., Corcoy, R., Mahmood, T., Nizard, J., Savona-Ventura, C., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3615-7 · Cited by 72
“Some countries and regions in Europe use selective screening with the previous WHO diagnostic criteria (the UK and the Netherlands, for example), while others use the ACOG screening strategy (the Flemish part of Belgium, for example) [24, 29, 30].”
BackgroundMethodSelf-citationBenhalima, K., Mathieu, C., Van Assche, A., Damm, P., Devlieger, R., Mahmood, T., & Dunne, F. (2016) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2016.04.003 · Cited by 63
Self-citationBenhalima, K., Robyns, K., Van Crombrugge, P., Deprez, N., Seynhave, B., Devlieger, R., Verhaeghe, J., Mathieu, C., & Nobels, F. (2015) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-015-0706-x · Cited by 55
Self-citationGlucose Intolerance after a Recent History of Gestational Diabetes Based on the 2013 WHO Criteria
Benhalima, K., Jegers, K., Devlieger, R., Verhaeghe, J., & Mathieu, C. (2016) · PLOS ONE · doi:10.1371/journal.pone.0157272 · Cited by 45
Self-citation
Metadata
- Authors
- Benhalima, K., Van Crombrugge, P., Devlieger, R., Verhaeghe, J., Verhaegen, A., De Catte, L., & Mathieu, C.
- Venue
- Diabetology & Metabolic Syndrome
- Published
- 2013-11-11
- Volume
- 5
- Issue
- 1
- Pages
- 66-66
- ISSN
- 1758-5996 (ISSN-L)
- OpenAlex
- W2102602272
- Cited by
- 18
- References
- 5
- FWCI
- 3.06
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Screening for pregestational and gestational diabetes in pregnancy: a survey of obstetrical centers in the northern part of Belgium. https://app.cochat.ai/papers/10.1186/1758-5996-5-66
- The paper
- Benhalima, K., Van Crombrugge, P., Devlieger, R., Verhaeghe, J., Verhaegen, A., De Catte, L., & Mathieu, C. (2013). Screening for pregestational and gestational diabetes in pregnancy: a survey of obstetrical centers in the northern part of Belgium. Diabetology & Metabolic Syndrome. https://doi.org/10.1186/1758-5996-5-66
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.